Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)
June 25 2021 - 4:57PM
Edgar (US Regulatory)
June 25, 2021
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
|
|
|
|
|
|
Re:
|
Notice of disclosure filed in Annual Report on Form 10-K under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the U.S. Securities Exchange Act of 1934, as amended
|
Ladies and Gentlemen,
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the U.S. Securities Exchange Act of 1934, as amended, notice is hereby provided that Medtronic plc has made disclosure pursuant to such provisions in its Annual Report on Form 10-K dated April 30, 2021, which was filed with the U.S. Securities and Exchange Commission on June 25, 2021.
Sincerely,
Medtronic plc
|
|
|
/s/ Karen L. Parkhill
|
Karen L. Parkhill
|
Executive Vice President and Chief Financial Officer
|
Medtronic (NYSE:MDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Sep 2023 to Sep 2024